Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pompe Disease Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pompe Disease Drugsmarket, defines the market attractiveness level of Pompe Disease Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pompe Disease Drugs industry, describes the types of Pompe Disease Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pompe Disease Drugs market and the development prospects and opportunities of Pompe Disease Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pompe Disease Drugs market in Chapter 13.
By Player:
Sangamo
Genzyme?A Sanofi Company)
Valerion Therapeutics
Amicus
Audentes
EpiVax
BioMarin
Oxyrane
By Type:
Liver Drugs
Heart Drugs
Muscle Drugs
By End-User:
Hospital
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pompe Disease Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pompe Disease Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pompe Disease Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pompe Disease Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pompe Disease Drugs Market Analysis and Outlook to 2022
-
7.1 Global Pompe Disease Drugs Consumption (2017-2022)
-
7.2 United States Pompe Disease Drugs Consumption (2017-2022)
-
7.3 Europe Pompe Disease Drugs Consumption (2017-2022)
-
7.4 China Pompe Disease Drugs Consumption (2017-2022)
-
7.5 Japan Pompe Disease Drugs Consumption (2017-2022)
-
7.6 India Pompe Disease Drugs Consumption (2017-2022)
-
7.7 South Korea Pompe Disease Drugs Consumption (2017-2022)
8 Region and Country-wise Pompe Disease Drugs Market Analysis and Outlook to 2028
-
8.1 Global Pompe Disease Drugs Consumption Forecast (2022-2028)
-
8.2 United States Pompe Disease Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Pompe Disease Drugs Consumption Forecast (2022-2028)
-
8.4 China Pompe Disease Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Pompe Disease Drugs Consumption Forecast (2022-2028)
-
8.6 India Pompe Disease Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Pompe Disease Drugs Consumption Forecast (2022-2028)
9 Global Pompe Disease Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Pompe Disease Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Liver Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Heart Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Muscle Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Pompe Disease Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Pompe Disease Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Pompe Disease Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Liver Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Heart Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Muscle Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pompe Disease Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Pompe Disease Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pompe Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pompe Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pompe Disease Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pompe Disease Drugs Market Competitive Analysis
-
14.1 Sangamo
-
14.1.1 Sangamo Company Details
-
14.1.2 Sangamo Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sangamo Pompe Disease Drugs Product and Service
-
14.2 Genzyme?A Sanofi Company)
-
14.2.1 Genzyme?A Sanofi Company) Company Details
-
14.2.2 Genzyme?A Sanofi Company) Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Genzyme?A Sanofi Company) Pompe Disease Drugs Product and Service
-
14.3 Valerion Therapeutics
-
14.3.1 Valerion Therapeutics Company Details
-
14.3.2 Valerion Therapeutics Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Valerion Therapeutics Pompe Disease Drugs Product and Service
-
14.4 Amicus
-
14.4.1 Amicus Company Details
-
14.4.2 Amicus Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amicus Pompe Disease Drugs Product and Service
-
14.5 Audentes
-
14.5.1 Audentes Company Details
-
14.5.2 Audentes Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Audentes Pompe Disease Drugs Product and Service
-
14.6 EpiVax
-
14.6.1 EpiVax Company Details
-
14.6.2 EpiVax Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 EpiVax Pompe Disease Drugs Product and Service
-
14.7 BioMarin
-
14.7.1 BioMarin Company Details
-
14.7.2 BioMarin Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 BioMarin Pompe Disease Drugs Product and Service
-
14.8 Oxyrane
-
14.8.1 Oxyrane Company Details
-
14.8.2 Oxyrane Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Oxyrane Pompe Disease Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pompe Disease Drugs
-
Figure Pompe Disease Drugs Picture
-
Table Global Pompe Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pompe Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pompe Disease Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pompe Disease Drugs Consumption by Country (2017-2022)
-
Figure United States Pompe Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Pompe Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Pompe Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Pompe Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Pompe Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pompe Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Pompe Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Pompe Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pompe Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pompe Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pompe Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pompe Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pompe Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Heart Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Muscle Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Heart Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Muscle Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pompe Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pompe Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Sangamo (Foundation Year, Company Profile and etc.)
-
Table Sangamo Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Pompe Disease Drugs Product and Service
-
Table Genzyme?A Sanofi Company) (Foundation Year, Company Profile and etc.)
-
Table Genzyme?A Sanofi Company) Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme?A Sanofi Company) Pompe Disease Drugs Product and Service
-
Table Valerion Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Valerion Therapeutics Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valerion Therapeutics Pompe Disease Drugs Product and Service
-
Table Amicus (Foundation Year, Company Profile and etc.)
-
Table Amicus Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amicus Pompe Disease Drugs Product and Service
-
Table Audentes (Foundation Year, Company Profile and etc.)
-
Table Audentes Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Audentes Pompe Disease Drugs Product and Service
-
Table EpiVax (Foundation Year, Company Profile and etc.)
-
Table EpiVax Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table EpiVax Pompe Disease Drugs Product and Service
-
Table BioMarin (Foundation Year, Company Profile and etc.)
-
Table BioMarin Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioMarin Pompe Disease Drugs Product and Service
-
Table Oxyrane (Foundation Year, Company Profile and etc.)
-
Table Oxyrane Pompe Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oxyrane Pompe Disease Drugs Product and Service
-
